chr6-110424907-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000368919.8(SLC22A16):c.1700C>T(p.Ala567Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,613,946 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000368919.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A16 | NM_033125.4 | c.1700C>T | p.Ala567Val | missense_variant | 8/8 | ENST00000368919.8 | NP_149116.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A16 | ENST00000368919.8 | c.1700C>T | p.Ala567Val | missense_variant | 8/8 | 1 | NM_033125.4 | ENSP00000357915 | P2 | |
SLC22A16 | ENST00000330550.8 | c.1598C>T | p.Ala533Val | missense_variant | 10/10 | 1 | ENSP00000328583 | A2 | ||
SLC22A16 | ENST00000451557.5 | c.*449C>T | 3_prime_UTR_variant | 7/7 | 2 | ENSP00000395642 | ||||
SLC22A16 | ENST00000460159.1 | n.246C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251470Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135906
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461866Hom.: 1 Cov.: 30 AF XY: 0.0000358 AC XY: 26AN XY: 727228
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74286
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at